Brief

"On 27/11/2024, the Italian Medicines Agency (AIFA) issued an update regarding AIFA Board of Directors approves the reimbursability of 16 medicines. The approved medicines include 14 active principles, three orphan drugs for rare diseases, seven new molecules, and six extensions of therapeutic indications."

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies